Thierry HULOT
President
LEEM
France
Thierry Hulot, 58 years old, holds a degree in pharmacy and drug metabolism (René Descartes University and Paris Sud University). He also graduated with an MBA from Ashridge University (UK).
He joined the Delagrange laboratory in 1989 as a biopharmaceutical research officer. In 1992, he joined Synthélabo Research as a project manager in clinical pharmacokinetics.
Thierry Hulot joined the Merck Group in 1995, where he held various positions in R&D in France and Germany.
In 2007, he continued his activity in Switzerland at Merck Serono, after the acquisition of Serono by the Merck Group. He developed the Project Management function within the new company. He then headed the Office of the President of Merck Serono until 2012, before creating the Biosimilars business in 2013.
In October 2013, he was appointed Director of Industrial and Supply Activities worldwide.
Since February 1, 2017, Thierry Hulot has been Chairman and CEO of Merck in France (with 3 business areas: healthcare, life sciences, electronics). He is also Managing Director of the Biopharma division in France.
Thierry Hulot has been President of LEEM since July 5, 2022, for a 2-year mandate.